July 25, 2017
The Japan unit of Mundipharma said on July 24 that it has agreed with Janssen Pharmaceuticals Inc. of the US to acquire license rights to the cancer pain medicine Tapenta Tablets (tapentadol) in Japan. Tapenta was launched in 2014 by...read more